HhAntag

CAS No. 496794-70-8

HhAntag ( HhAntag; Hh-Antag; Hh Antag )

Catalog No. M17525 CAS No. 496794-70-8

HhAntag is a small molecule inhibitor of GLI1-mediated transcription, an essential down-stream element of the Hedgehog (Hh) pathway with the anti-tumor activity.

Purity : 96%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 102 In Stock
5MG 185 In Stock
10MG 320 In Stock
25MG 529 In Stock
50MG 771 In Stock
100MG 1062 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HhAntag
  • Note
    Research use only, not for human use.
  • Brief Description
    HhAntag is a small molecule inhibitor of GLI1-mediated transcription, an essential down-stream element of the Hedgehog (Hh) pathway with the anti-tumor activity.
  • Description
    HhAntag is a GLI1-mediated transcription inhibitor. It acts as an inhibitor of the Shh pathway.
  • Synonyms
    HhAntag; Hh-Antag; Hh Antag
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    Gli
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    496794-70-8
  • Formula Weight
    450.92
  • Molecular Formula
    C24H23ClN4O3
  • Purity
    96%
  • Solubility
    DMSO : ≥ 100 mg/mL. 221.77 mM; H2O : < 0.1 mg/mL
  • SMILES
    C(=O)(c1cc(cc(c1)OC)OC)Nc1cc(c(cc1)Cl)c1nc2c([nH]1)cc(cc2)N(C)C
  • Chemical Name
    N-[4-Chloro-3-[6-(dimethylamino)-1H-benzimidazol-2-yl]phenyl]-3,5-dimethoxybenzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Actis, Marcelo; Connelly, Michele C.; Mayasundari, Anand et al. Biopolymers (2011), 95(1), 24-30.
molnova catalog
related products
  • AM-0902

    AM-0902 is a potent and specific TRPA1 antagonist (IC50s: 71/131 nM for rTRPA1 and hTRPA1).

  • AMG-9810

    A potent, selective and competitive TRPV1 antagonist with IC50 of 24.5 and 85.6 nM for human and rat TRPV1, repectively.

  • L-R4W2

    Vanilloid TRPV1 (VR1) receptor antagonist peptide (IC50 ~ 0.1 μM); blocks Ca2+ currents in dorsal root ganglion neurons. Analgesic in vivo.